The gene expression changes in model cells aligned with gene expression changes observed in aneuploid cancers and uncovered the transcriptional factors E2F4 and FOXM1 to critically contribute to adaptation to chromosome gains, which we experimentally validated. The gene discussed is E2F4; the disease is cancer.